Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

497 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Prognostic Impact of Inflammation-Based Factors in Patients with Esophageal Squamous Cell Carcinoma Achieving Pathological Complete Response After Neoadjuvant Chemoradiotherapy Followed by Surgery.
Kim JY, Yun JK, Kim YH, Park SI, Lee JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Kim SB, Cho KJ, Ryu JS, Kim JH, Kang J, Park SR, Kim HR. Kim JY, et al. Among authors: choi kd. Ann Surg Oncol. 2024 Dec 11. doi: 10.1245/s10434-024-16679-7. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39661290 No abstract available.
Validation of the post-neoadjuvant staging system of the American joint committee on cancer, 8th edition, in patients treated with neoadjuvant chemoradiotherapy followed by curative esophagectomy for localized esophageal squamous cell carcinoma.
Kang J, Lee HP, Kim HR, Kim JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Ryu JS, Cho KJ, Lee MY, Kim SB, Kim YH, Park SR. Kang J, et al. Among authors: choi kd. Surg Oncol. 2020 Dec;35:491-497. doi: 10.1016/j.suronc.2020.10.015. Epub 2020 Oct 24. Surg Oncol. 2020. PMID: 33130441
Prognostic Impact of Inflammation-Based Factors in Patients with Esophageal Squamous Cell Carcinoma Achieving Pathological Complete Response After Neoadjuvant Chemoradiotherapy Followed by Surgery.
Kim JY, Yun JK, Kim YH, Park SI, Lee JH, Jung HY, Lee GH, Song HJ, Kim DH, Choi KD, Ahn JY, Kim SB, Cho KJ, Ryu JS, Kim JH, Kang J, Park SR, Kim HR. Kim JY, et al. Among authors: choi kd. Ann Surg Oncol. 2024 Oct;31(10):6662-6672. doi: 10.1245/s10434-024-15678-y. Epub 2024 Jul 2. Ann Surg Oncol. 2024. PMID: 38954089
Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy.
Kim MK, Kim SB, Ahn JH, Kim YH, Kim JH, Jung HY, Lee GH, Choi KD, Song HY, Shin JH, Cho KJ, Ryu JS, Park SI. Kim MK, et al. Among authors: choi kd. Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):725-34. doi: 10.1016/j.ijrobp.2007.10.009. Epub 2007 Dec 31. Int J Radiat Oncol Biol Phys. 2008. PMID: 18164836 Clinical Trial.
Initial stage affects survival even after complete pathologic remission is achieved in locally advanced esophageal cancer: analysis of 70 patients with pathologic major response after preoperative chemoradiotherapy.
Kim MK, Cho KJ, Park SI, Kim YH, Kim JH, Song HY, Shin JH, Jung HY, Lee GH, Choi KD, Song HJ, Ryu JS, Kim SB. Kim MK, et al. Among authors: choi kd. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):115-21. doi: 10.1016/j.ijrobp.2008.10.074. Epub 2009 Feb 27. Int J Radiat Oncol Biol Phys. 2009. PMID: 19251379
Feasibility of endoscopic resection in superficial esophageal squamous carcinoma.
Choi JY, Park YS, Jung HY, Ahn JY, Kim MY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Cho KJ, Kim JH. Choi JY, et al. Among authors: choi ks, choi kd. Gastrointest Endosc. 2011 May;73(5):881-9, 889.e1-2. doi: 10.1016/j.gie.2010.12.028. Epub 2011 Mar 9. Gastrointest Endosc. 2011. PMID: 21392755
Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH, Park SI, Kim YH, Kim JH, Jung HY, Lee GH, Choi KD, Song HJ, Song HY, Shin JH, Cho KJ, Yoon DH, Kim SB. Koo DH, et al. Among authors: choi kd. Cancer Chemother Pharmacol. 2012 Mar;69(3):655-63. doi: 10.1007/s00280-011-1750-5. Epub 2011 Oct 4. Cancer Chemother Pharmacol. 2012. PMID: 21968953 Clinical Trial.
497 results